| |
Arthritis News Archive14-Apr-2008
Arthritis Foundation elects board member (Lawrence Journal-World)
Kristin Piper, Lawrence, has been elected to serve a three-year term on the board of directors for the Kansas Chapter of the arthritis Foundation.
It's Not Just Your Grandma's Ailment: Arthritis Common in Children (Newswise)
Aches and pains are common in children and teens. Most of the time, they are fairly benign and dismissed as growing pains. However, musculoskeletal pains can signal several serious conditions, says Sangeeta Sule, M.D., pediatric rheumatologist at Johns Hopkins Children's Center, including juvenile rheumatoid arthritis (JRA), the most common form of arthritis in children and teens.
New Consumer and Clinician Guides on Benefits, Risks of Rheumatoid Arthritis Medicines (Newswise)
A new pair of plain language guides -- one for consumers and one for clinicians -- draws on unbiased scientific evidence to compare rheumatoid arthritis drugs, including their clinical benefits, risks and cost estimates.
Check your pet for arthritis (Esperance Express)
WITH arthritis week in full swing, it may be time to remember that man?s best friend can also suffer from the potentially debilitating joint condition.
Arthritis drug to be tested (Press & Sun-Bulletin)
Dr. Bruce Bowling of Endwell Family Physicians in Endwell is conducting a clinical study of a new drug that could halt progression of arthritis.
Starpharma Holdings Announces Dendrimer SPL7013 Potential Application for Arthritis (SPL.AX, 00832042, 20080414) (Huntleys' Stock of the Week via Yahoo!7 Finance)
Starpharma Holdings announced it has filed a patent application for the use of SPL7013, the active ingredient in VivaGel, to inhibit hyaluronidase activity in the treatment or prevention of a number of diseases. The inhibitory activity was discovered during studies on the contraceptive activity of SPL7013, in which effects on hyaluronidase were examined due to the enzyme's involvement in the ...
Baby boomers confront arthritis (Florence Morning News)
Baby Boomers ? once the generation of peace and love ? have evolved. Let's just call them the generation of aches and pains. This group of more than 73 million Americans is heading past middle age, and is starting to get familiar with ailments often associated with the elderly. At the top of the list: arthritis, the painful inflammation of joints caused by the deterioration of ...
Axis-Shield granted umbrella patent for arthritis test (The Herald)
AXIS-Shield, the Scottish-Norwegian maker of medical diagnostic kits, yesterday announced that the US Patent Office had granted an umbrella patent governing use of cyclic citrullinated peptides (CCP) in the diagnosis and monitoring of rheumatoid arthritis, which covers the company's anti-CCP arthritis test.
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|